Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
12.65
+0.01 (0.08%)
May 20, 2026, 1:34 PM CST
Jiangsu Yahong Meditech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 628.45 | 779.45 | 628.2 | 1,738 | 1,035 | 2,613 |
Short-Term Investments | - | 161.24 | 150.54 | 14.54 | - | - |
Trading Asset Securities | 754.25 | 668 | 657.21 | 594.31 | 1,703 | 369.77 |
Cash & Short-Term Investments | 1,383 | 1,609 | 1,436 | 2,347 | 2,738 | 2,983 |
Cash Growth | -17.14% | 12.03% | -38.82% | -14.29% | -8.20% | 273.49% |
Accounts Receivable | 104.34 | 98.56 | 59.9 | 8.68 | 0.02 | 0 |
Other Receivables | 3.85 | 6.46 | 11.63 | 5.9 | 3.04 | 2.07 |
Receivables | 108.19 | 105.02 | 71.53 | 14.57 | 3.06 | 2.08 |
Inventory | 18.01 | 21.92 | 5.84 | 1.61 | 2.79 | 3.81 |
Other Current Assets | 126.19 | 26.12 | 17.63 | 12.2 | 15.93 | 19.79 |
Total Current Assets | 1,635 | 1,762 | 1,531 | 2,375 | 2,760 | 3,009 |
Property, Plant & Equipment | 66.22 | 73.49 | 85.45 | 88.5 | 36.8 | 26.88 |
Long-Term Investments | 115.28 | 99.85 | 474.22 | 26.41 | 15.34 | - |
Other Intangible Assets | 68.97 | 73.68 | 53.98 | 61.39 | 21.79 | 22.13 |
Long-Term Deferred Tax Assets | 2.25 | 2.4 | 2.09 | 1.26 | 0.25 | - |
Long-Term Deferred Charges | 64.99 | 4.5 | 5.96 | 9.86 | 12.13 | 7.79 |
Other Long-Term Assets | 42.37 | 41.83 | 70.35 | 69.4 | 27.64 | 33.43 |
Total Assets | 1,995 | 2,057 | 2,223 | 2,632 | 2,874 | 3,099 |
Accounts Payable | 52.69 | 51.54 | 47.26 | 59.22 | 43.65 | 33.57 |
Accrued Expenses | 20.12 | 80.56 | 55.32 | 38.42 | 24.64 | 32.92 |
Short-Term Debt | 200.29 | 238.5 | 66.25 | 73.4 | - | - |
Current Portion of Long-Term Debt | 18.97 | 1.3 | - | - | - | - |
Current Portion of Leases | - | 17.91 | 14.34 | 10.29 | 7.37 | 5.66 |
Current Income Taxes Payable | 3.95 | - | 0.31 | 0.34 | 1.52 | - |
Current Unearned Revenue | 0.22 | 0.22 | 0.31 | - | - | - |
Other Current Liabilities | 105.15 | 12.36 | 13.28 | 3.67 | 3.48 | 1.74 |
Total Current Liabilities | 401.38 | 402.4 | 197.06 | 185.35 | 80.66 | 73.89 |
Long-Term Debt | 104.21 | 48.44 | - | - | - | - |
Long-Term Leases | 33.82 | 39 | 49.95 | 50.77 | 11.31 | 11.76 |
Long-Term Unearned Revenue | 4.46 | 4.6 | 5.61 | 6.39 | 11 | 0.32 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0 | - |
Total Liabilities | 543.87 | 494.44 | 252.62 | 242.5 | 102.98 | 85.98 |
Common Stock | 571.17 | 571.17 | 570 | 570 | 570 | 570 |
Additional Paid-In Capital | 2,908 | 2,907 | 2,884 | 2,863 | 2,848 | 2,841 |
Retained Earnings | -1,957 | -1,845 | -1,429 | -1,045 | -644.27 | -397.92 |
Treasury Stock | -50.06 | -50.06 | -50.06 | - | - | - |
Comprehensive Income & Other | -5.32 | -6.74 | -5.54 | -0.38 | -2.44 | - |
Total Common Equity | 1,467 | 1,576 | 1,969 | 2,388 | 2,771 | 3,013 |
Minority Interest | -15.44 | -13.28 | 0.97 | 1.8 | - | - |
Shareholders' Equity | 1,451 | 1,563 | 1,970 | 2,390 | 2,771 | 3,013 |
Total Liabilities & Equity | 1,995 | 2,057 | 2,223 | 2,632 | 2,874 | 3,099 |
Total Debt | 357.29 | 345.15 | 130.54 | 134.46 | 18.69 | 17.42 |
Net Cash (Debt) | 1,025 | 1,264 | 1,305 | 2,213 | 2,720 | 2,966 |
Net Cash Growth | -31.57% | -3.21% | -41.00% | -18.64% | -8.29% | 271.31% |
Net Cash Per Share | 1.82 | 2.25 | 2.31 | 3.70 | 4.74 | 6.44 |
Filing Date Shares Outstanding | 561.99 | 562.5 | 561.33 | 570 | 570 | 570 |
Total Common Shares Outstanding | 561.99 | 562.5 | 561.33 | 570 | 570 | 570 |
Working Capital | 1,234 | 1,359 | 1,334 | 2,190 | 2,679 | 2,935 |
Book Value Per Share | 2.61 | 2.80 | 3.51 | 4.19 | 4.86 | 5.29 |
Tangible Book Value | 1,398 | 1,503 | 1,915 | 2,327 | 2,749 | 2,991 |
Tangible Book Value Per Share | 2.49 | 2.67 | 3.41 | 4.08 | 4.82 | 5.25 |
Machinery | - | 52.29 | 49.56 | 46.55 | 27.8 | 15.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.